Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 2:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1153–1176 of 1,734 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: work therapy Clear all

Conditions: Alcohol Use, Drug Use, Risk Behavior, Sexual Behavior
Interventions: Contingency management, Employment Only; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: StayQuit Intervention
Interventions: StayQuit; Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Breast Cancer
Interventions: Trastuzumab, GDC-0084; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Depression, Borderline Personality Disorder, Emotion Regulation
Interventions: Psychotherapy, Positive Affect Promoting Activities, Psychotherapy; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Obstructive Sleep Apnea
Interventions: BONGO NASAL EPAP; Device
Lead sponsor: InnoMed Healthscience Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Opioid Dependence
Interventions: Strengths-based Case Management (SBCM), Screening, Assessment, and Referral (SAR); Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Nonalcoholic Fatty Liver Disease
Interventions: Diabetes Prevention Program; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Depression, Breast Cancer Screening, Cervical Cancer Screening, Colorectal Cancer Screening
Interventions: Prevention Care Management for Depression and Cancer Screening, Prevention Care Management for Cancer Screening; Behavioral
Lead sponsor: Clinical Directors Network; Network
Eligibility: 50 Years to 64 Years · Female only
Enrollment: 802 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 8
States / cities: The Bronx, New York

Conditions: Protein Metabolism
Interventions: Resistance Exercise, No Resistance Exercise, Leucine, Dileucine; Behavioral · Dietary Supplement
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 35 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Opioid-use Disorder, Overdose
Interventions: buprenorphine/naloxone; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Major Depressive Disorder
Interventions: Intermittent Theta Burst Stimulation (iTBS); Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Malignant Brain Tumors
Interventions: Research Questionnaires, Palliative Care Team, Educational Information Session for Patients and Caregivers, Contact every 2 weeks, Follow-up Surgical Visit Session, Medical and/or Radiation Oncology Appointment Session; Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Basal Cell Carcinoma, Basal Cell Nevus Syndrome
Interventions: Dietary Vitamin D3 pre-treatment, Photodynamic therapy, Serum Maintenance Vitamin D3; Drug · Radiation
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: Not listed
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 2
States / cities: Phoenix, Arizona • Cleveland, Ohio

Conditions: Acute Coronary Syndromes
Interventions: Non-Interventional Study; Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 55
States / cities: Birmingham, Alabama • Mobile, Alabama • Little Rock, Arkansas + 45 more

Conditions: Congenital Bleeding Disorder, Haemophilia A
Interventions: Turoctocog alfa pegol; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: Male only
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 18
States / cities: Phoenix, Arizona • Long Beach, California • Iowa City, Iowa + 15 more

Conditions: HIV, AIDS, Substance Abuse, Inpatient
Interventions: Patient Navigation (PN) Group, Patient Navigator Plus Contingency Management (PN+CM) Group; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 801 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 12
States / cities: Birmingham, Alabama • Torrance, California • Miami, Florida + 8 more

Conditions: Tobacco Dependence, Withdrawal Symptoms, Smoking Cessation
Interventions: 1.0mg Varenicline b.i.d., 0.5mg Varenicline b.i.d., 0.0mg placebo Varenicline b.i.d.; Drug
Lead sponsor: Arizona State University; Other
Eligibility: 21 Years and older
Enrollment: 313 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: Phoenix, Arizona • Burbank, California

Conditions: Major Depressive Disorder
Interventions: Ketamine, Psychotherapy; Drug · Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 90 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Sarcoma
Interventions: Interview, Observations, Guided Activities; Behavioral
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 7 Years to 11 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Obesity
Interventions: Weekly Internet surveys; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Hand Hygiene Effectiveness
Interventions: hand antiseptic with CHG and alcohol, Alcohol hand sanitizer foam; Drug
Lead sponsor: Solventum US LLC; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Opioid-use Disorder
Interventions: PROUD Intervention; Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 16 Years to 90 Years
Enrollment: 377,373 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 6
States / cities: Miami, Florida • Detroit, Michigan • The Bronx, New York + 3 more

Conditions: HIV, Pre-exposure Prophylaxis, Case Management, Contingency Management
Interventions: Dyadic Case Management; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Pain
Interventions: Cognitive Behavioral Therapy (CBT), Exercise Counseling and tele-EnhanceFitness, Care Coordination, Standard Clinical Practice Regimen; Behavioral · Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Search by objective public record fields.

Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1

Helping Veterans With SMI "StayQuit" From Smoking After Inpatient Hospitalization

GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases

Incorporating Positive Affect Promoting Activities Into Cognitive Behavioral Therapies

Clinical Study for the BONGO NASAL Expiratory Positive Airway Pressure (EPAP) Device in the Treatment of Obstructive Sleep Apnea (OSA)

Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments

Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease

Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women

Skeletal Muscle Protein Synthetic Response to Amino Acid and Peptides

Rapid Initiation of Drug Treatment Engagement

Targeting Specific Brain Networks to Treat Specific Symptoms in Depression

PRESENCE Project: An Early Palliative Care Intervention in Brain Tumors

Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma

Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users

Varenicline OTC Trial on Efficacy and Safety

Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression

A Qualitative Case Study of the Experiences of Children With Cancer as They Learn About Their Diagnosis and Treatment

Multivitamin Adherence Following Bariatric Surgery

Evaluation of Two Hand Hygiene Products in ICUs

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

Case Management Dyad

Adapting and Implementing a Nurse Care Management Model to Care for Rural Patients With Chronic Pain